与潜在基因表达模式相关的影像组学特征用于预测肝细胞癌预后和治疗反应
本研究基于治疗前CT图像构建影像组学特征,在经TACE治疗的肝细胞癌训练集中用LASSO-COX回归预测总生存,并在TCGA的41例患者中外部验证;高、低风险组生存差异显著,5年OS的AUC分别为0.730和0.695,并鉴定出7个与OS相关的基因。
要点
- 基于治疗前CT的影像组学评分可将HCC患者分为高、低风险组,两组生存差异显著。
- 训练集与外部测试集5年OS的AUC分别为0.730和0.695。
- 鉴定出7个OS相关基因,除MAFG外均与TACE疗效相关。
核心结论
- CT影像组学特征可有效预测HCC的预后和治疗反应,并与肿瘤微环境异质性相关。
研究设计与样本
- 回顾性研究,纳入三个数据集中经病理或临床证实的HCC患者共752例。
- 院内接受TACE治疗的数据作为训练集构建影像组学特征,采用LASSO-COX回归算法预测OS。
- 模型在TCGA中41例有可用CT图像的患者中进行外部测试。
诊断标准与关键数值
- 影像组学评分将患者分为高风险组和低风险组,训练集与外部测试集生存差异P值分别为P < 0.0001和P = 0.0055。
- 训练集5年OS的AUC为0.730,外部测试集5年OS的AUC为0.695。
- 鉴定出7个OS相关基因:SPP1、GJA5、GJA4、INMT、PDZD4、ALDOA和MAFG,除MAFG外均与TACE疗效相关(MAFG的P greater than 0.05)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Identifying robust prognosis and treatment efficiency predictive biomarkers of hepatocellular carcinoma (HCC) is challenging. The purpose of this study is to develop a radiomics approach for predicting the overall survival (OS) based on pretreatment CT images and to explore the radiomic-associated key genes.
METHODS: Patients with pathologically or clinically proven HCC from three data sets were retrospectively included in this study. The institute internal data that received transarterial chemoembolization (TACE) treatment was used as the training set to construct the radiomics signature to predict OS by the least absolute shrinkage and selection operator COX (LASSO-COX) regression algorithms. The model was externally tested in 41 patients from The Cancer Genome Atlas (TCGA) with available CT images. Area under the receiver operating characteristics curve (AUC) and the log-rank test were used for survival analysis based on high versus low radiomics score. RNA sequencing data of TCGA and Gene Expression Omnibus (GEO) public database were used for gene expression analysis.
RESULTS: A total of 752 patients were divided into the Radiomics cohort (n = 267), the TCGA cohort (n = 338) and GEO cohort (n = 147). The rad-score divided patients into high and low risk groups, with significant survival differences (P < 0.0001 and P = 0.0055) in the training and external test set. The AUC for 5 years' OS were 0.730 and 0.695, respectively. Seven OS-related genes (SPP1, GJA5, GJA4, INMT, PDZD4, ALDOA and MAFG) were identified, all of which were related with TACE efficiency, except for MAFG (P greater than 0.05).
CONCLUSIONS: CT-radiomics signature could effectively predict the prognosis and treatment response of HCC, which were also associated with the tumor microenvironment heterogeneity.
引用
- Wang D, Zhang L, Sun Z, et al. A radiomics signature associated with underlying gene expression pattern for the prediction of prognosis and treatment response in hepatocellular carcinoma. Eur J Radiol. 2023. PMID: 37708675. doi:10.1016/j.ejrad.2023.111086
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。